Context Therapeutics (CNTX) Stock Chart & Stock Price History $0.63 +0.00 (+0.69%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$0.65 +0.02 (+3.36%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Context Therapeutics Stock Price Performance The Context Therapeutics (CNTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 64.70%, with a year-to-date return of -39.83%. In the past month, the stock has increased 8.56%, reflecting recent market activity. As of the latest close, Context Therapeutics traded at $0.63 with a market cap of $56.67 million and volume of 95,743 shares. Receive CNTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Context Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.30%1 Month Performance+8.56%3 Month Performance-12.13%Year-To-Date Performance-39.83%1 Year Performance-64.70% CNTX Stock Chart for Thursday, July, 3, 2025 CNTX Chart by TradingView Context Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/02/2025$0.63$0.63+0.69%$0.66$0.6295,743 shs$56.67 million07/01/2025$0.66$0.63-4.23%$0.68$0.63190,117 shs$56.29 million06/30/2025$0.66$0.66-0.76%$0.70$0.62161,433 shs$58.77 million06/27/2025$0.65$0.66+1.37%$0.66$0.6387,365 shs$59.22 million06/26/2025$0.65$0.65-0.53%$0.65$0.62134,397 shs$58.42 million06/25/2025$0.58$0.65+13.72%$0.66$0.58165,765 shs$58.74 million06/24/2025$0.56$0.58+2.20%$0.61$0.56180,648 shs$51.65 million06/23/2025$0.57$0.56-1.61%$0.60$0.56241,771 shs$50.54 million06/20/2025$0.56$0.57+1.58%$0.62$0.57151,137 shs$51.37 million06/19/2025$0.56$0.56$0.63$0.56171,286 shs$50.56 million Get the Latest News and Ratings for CNTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Context Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/18/2025$0.58$0.56-2.34%$0.63$0.56171,286 shs$50.56 million06/17/2025$0.61$0.58-5.30%$0.60$0.57180,878 shs$51.78 million06/16/2025$0.63$0.61-3.16%$0.63$0.61186,477 shs$54.68 million06/13/2025$0.65$0.63-3.56%$0.64$0.61170,618 shs$56.46 million06/12/2025$0.62$0.65+5.21%$0.66$0.62269,544 shs$58.54 million06/11/2025$0.67$0.62-7.21%$0.72$0.601.49 million shs$55.64 million06/10/2025$0.70$0.67-4.89%$0.80$0.65417,317 shs$59.97 million06/09/2025$0.66$0.70+5.84%$0.84$0.661.11 million shs$63.05 million06/06/2025$0.55$0.66+20.40%$0.70$0.55400,339 shs$59.57 million06/05/2025$0.58$0.55-4.12%$0.60$0.54291,195 shs$49.48 million06/04/2025$0.58$0.58-1.15%$0.60$0.5298,639 shs$51.61 million06/03/2025$0.59$0.58-1.02%$0.63$0.53402,221 shs$52.21 million06/02/2025$0.59$0.59+0.34%$0.63$0.52232,566 shs$52.75 million Related Companies IMAB Stock Price Chart PRQR Stock Price Chart SOPH Stock Price Chart SCPH Stock Price Chart MNPR Stock Price Chart YMAB Stock Price Chart CRGX Stock Price Chart GNFT Stock Price Chart PROK Stock Price Chart DRUG Stock Price Chart Receive CNTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Context Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CNTX) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Context Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Context Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
